New drug cocktail shows promise against tough lung cancer before surgery
Disease control
Recruiting now
This study tests a new treatment approach for people with a specific type of lung cancer (KRAS G12C mutation) that can be removed by surgery. About 30 participants will receive a targeted pill (fulzerasib) for 6 weeks, followed by a short break, then 3 cycles of immunotherapy (si…
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC